Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours

Journal of Pathology

Volumn 191, Issue 2, 2000, Pages 162-169

  Schulz, Stephan ^a   Becker, Karl Friedrich ^a,b   Braungart, Evelyn ^a   Reichmuth, Claudia ^a   Klamt, Barbara ^c   Becker, Ingrid ^a   Atkinson, Mike ^b   Gessler, Manfred ^c   Höfler, Heinz ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cadherin 11; cDNA; E cadherin; Expression; LOH; Nephroblastoma; Sequence; Wilms' tumour

Indexed keywords

NERVE CELL ADHESION MOLECULE; UVOMORULIN;

ARTICLE; DNA SEQUENCE; EPITHELIUM CELL; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MOLECULAR GENETICS; NEPHROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0034041395     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200006)191:2<162::AID-PATH604>3.0.CO;2-8     Document Type: Article

References (39)

1. Fearon ER, Vogelstein B, Feinberg AP. Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumors. Nature 1984; 309: 176-178.
2. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP. Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990; 343: 774-778.
3. Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990; 60: 509-520.
4. Varanasi R, Bardeesy N, Gharemani M, et al. Fine structure analysis of the WT1 gene in sporadic Wilms' tumors. Proc Natl Acad Sci U S A 1994; 91: 3554-3558.
5. Little M, Wells C. A clinical overview of WT1 mutations. Hum Mutat 1997; 9: 209-225.
6. Henry I, Grandjouan S, Couillin P, et al. Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms' tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci U S A 1989; 86: 3247-3251.
7. Wadey RB, Pal N, Buckle B, Yeomans E, Pritchard J, Cowell JK. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11. Oncogene 1990; 5: 901-907.
8. Dowdy SF, Fasching CL, Araujo D, et al. Suppression of tumorigenicity in Wilms' tumor by the p15.5 p14 region of chromosome 11. Science 1991; 254: 293-295.
9. Coppes MJ, Bonetta L, Huang A, et al. Loss of heterozygosity mapping in Wilms' tumor indicates the involvement of three distinct regions and a limited role for non-disjunction or mitotic recombination. Genes Chromosomes Cancer 1992; 5: 326-334.
10. Maw MA, Grundy PE, Millow LJ, et al. A third Wilms' tumor locus on chromosome 16q. Cancer Res 1992; 52: 3094-3098.
11. Austry E, Candon S, Henry I, et al. Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis. Genes Chromosomes Cancer 1995; 12: 285-294.
12. Grundy PE, Telzerow PE, Breslow N, Moskess J, Huff V, Paterson MC. Loss of heterozygosity for chromosome 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res 1994; 54: 2331-2333.
13. Grundy P, Telzerow P, Moksness J, Breslow NE. Clinicopathologic correlates of loss of heterozygosity for chromosome 16q and 1p in Wilms' tumor: a preliminary analysis. Med Pediatr Oncol 1996; 27: 429-433.
14. Klamt B, Schulze M, Thate C, et al. Allele loss in Wilms' tumors of chromosome arms 11q, 16q, and 22q correlates with clinicopathological parameters. Genes Chromosomes Cancer 1998; 22: 287-294.
15. Piepenhagen PA, Nelson WJ. Biogenesis of polarized epithelial cells during kidney development in situ: roles of E-cadherin-mediated cell cell adhesion and membrane cytoskeleton organization. Mol Biol Cell 1998; 11: 3161-3177.
16. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998; 153: 333-339.
17. Becker K-F, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845-3852.
18. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402-405.
19. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995; 14: 6107-6115.
20. Risinger JI, Berchuk A, Kohler MF, Boyd J. Mutations of the E-cadherin gene in human gynecologic cancers. Nature Gen 1994; 7: 98-102.
21. Simmoneau L, Kitagawa M, Suzuki S, Thiery JP. Cadherin-11 expression marks the mesenchymal phenotype: towards functions for cadherins? Cell Adhes Commun 1995; 3: 115-130.
22. Markus MA, Reichmuth C, Atkinson MJ, et al. Cadherin-11 is highly expressed in rhabdomyosarcomas and during differentiation of myoblasts in vitro. J Pathol 1999; 187: 164-172.
23. Cho EU, Patterson LT, Brookhiser WT, Mah S, Kintner C, Dressler GR. Differential expression and function of cadherin 6 during renal epithelium development. Development 1998; 125: 803-812.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1989; 7.46.
25. Becker KF, Höfler H. Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinoma. J Natl Cancer Inst 1995; 87: 1082-1084.
26. Becker KF, Reich U, Schott C, Höfler H. Single nucleotide polymorphisms in the human E-cadherin gene. Hum Genet 1995; 96: 739-740.
27. Braungart E, Schuhmacher C, Hartmann E, et al. Functional loss of E-cadherin and cadherin-11 alleles on chromosome 16q22 in colonie cancer. J Pathol 1999; 187: 530-534.
28. Becker KF, Reich U, Schott C, et al. Identification of eleven novel tumor-associated E-cadherin mutations. Hum Mut 1999; 13: 171.
29. Handschuh G, Candidus S, Luber B, et al. Tumor associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 1999; 18: 4301-4312.
30. Kremmidiotis G, Baker E, Crawford J, Eyre HJ, Nahmias J, Callen DF. Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity. Genomics 1998; 49: 467-471.
31. Van der Wurf AAM, Ten Kate J, Van der Linden EPM, Dinjens WNM, Arends JW, Bosman F. L-cam expression in normal, premalignant, and malignant colon mucosa. J Pathol 1992; 168: 287-291.
32. Eidelmann S, Damsky CH, Wheelock MJ, Damjanov I. Expression of the cell cell adhesion glycoprotein cell-cam 120/ 80 in normal human tissues and tumors. Am J Pathol 1989; 135: 101-110.
33. Shiozaki H, Tahara H, Oka H, et al. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 1991; 139: 17-23.
34. Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N, Niitsu S. Loss of E-cadherin-dependent cell cell adhesion due to mutation of the β-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 1995; 15: 1175-1181.
35. Ewing CM, Ru N, Morton RA, et al. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with reexpression of a catenin and restoration of E-cadherin. Cancer Res 1995; 55: 4813-4817.
36. Kraus C, Liehr T, Hulsken J, Behrens J, Birchmeier W. Localization of the human beta-catenin gene (CTNNBI) to 3p21: a region implicated in tumor development. Genomics 1994; 23: 272-274.
37. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190-193.
38. Gluer S, Zense M, von Schweinitz D. Cell adhesion molecules and intermediate filaments on embryonal childhood tumors. Pathol Res Pract 1998; 194: 773-780.
39. Nieman MT, Kim JB, Johnson KR, Wheelock MJ. Mechanism of extracellular domain-deleted dominant negative cadherins. J Cell Sci 1999; 112: 1621-1632.